Antitumor enzyme: polyethylene glycol-modified asparaginase.
Wada
H
H
Department of Pharmacology II, Osaka University School of Medicine, Japan.
Imamura
I
I
Sako
M
M
Katagiri
S
S
Tarui
S
S
Nishimura
H
H
Inada
Y
Y
D000293:Adolescent; D000328:Adult; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001215:Asparaginase / Q000009:adverse effects / Q000627:therapeutic use*; D004283:Dog Diseases; D004285:Dogs; D004800:Enzymes, Immobilized / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D008223:Lymphoma / Q000188:drug therapy* / Q000662:veterinary; D008297:Male; D051379:Mice; D011092:Polyethylene Glycols / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D004800:Enzymes, Immobilized; D011092:Polyethylene Glycols; C042705:pegaspargase; D001215:Asparaginase